|
Plaque psoriasis is a chronic, immune-mediated inflammatory skin disease that can significantly affect patients’ quality of life. While traditional systemic and topical treatments are effective for many individuals with mild to moderate disease, patients with refractory or severe psoriasis may require advanced therapeutic options. This session will review the mechanisms of action, efficacy, safety, and place in therapy for newly approved targeted agents for plaque psoriasis. Pharmacists and technicians will gain the knowledge needed to identify candidates for targeted therapy, support monitoring and adherence, and collaborate effectively within the healthcare team to optimize patient outcomes.
Course Details
Date: Thursday, December 4, 2025
Time: 2 p.m. to 3 p.m. via webinar
(Webinar will also be available on demand following the event if your schedule does not allow for live viewing.)
Presented by:
Stephen Lee, Pharm.D. • Instructional Professor and Interim Department Head of Pharmacy Practice, Texas A&M University College of Pharmacy
CE Credit:
This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program
has been approved for 1.0 contact hours of continuing education credit (0.1 CEU).
- Pharmacists: 0154-0000-25-039-L01-P
- Technicians: 0154-0000-25-039-L01-T
Pricing:
Members: FREE (Log in to your TPA account to receive free CE.)
Non-Members: $25
Learning Objectives:
At the completion of this activity, the pharmacist will be able to: - Discuss the properties of the targeted therapy for the treatment of plaque psoriasis.
- Given a patient case, discuss the appropriate use and monitoring for these targeted therapies for plaque psoriasis.
At the completion of this activity, the pharmacy technician will be able to: - Recognize the common classes of targeted therapies used in the treatment of plaque psoriasis.
- Assist pharmacists in patient education and adherence strategies for complex or specialty psoriasis medications.
|
